Medical Marijuana, Inc. Announces Key Executive Team Hire and Promotions

SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has made several promotions within the organization. 

The Company has promoted Todd Morrow, who will now serve as the Chief Financial and Information Officer (CFIO). Michelle Sides, Esq. has been named as the Company’s Chief Legal Officer. 

In addition, the Company has hired Robert A. Wells Jr. to serve as its Vice President of Finance.

Wells was chosen for this position due to his decades of success serving in key financial roles at consumer-facing companies. Most recently, he served as Chief Financial Officer and Chief Operating Officer of DC Labs & EQyss Grooming Products. While there, he planned, implemented and managed the company’s popular product inventory to ensure product demands were met and scaled appropriately. Previously, he served as CFO of the San Diego Padres for 16 years, Chief Operating Officer (COO) and CFO of Anthony Robbins Companies and COO and CFO of DoorTech Industries.

“Our Company is well supported by its employees and thus far we’ve been able to curate some of the most talented professionals in the industry,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “As we look forward to updated management roles and new personnel, we are confident in continuing our Company vision as a pioneer in the US Cannabidiol (CBD) market that is expected to reach  by 2025.”

While serving as Chief Information Officer, Morrow successfully lead strategic decision-making, cross-collaboration and driving greater profitability within the organization's family of companies. As CFIO, Morrow will continue to support the Company’s financial success through his keen eye for consumer demand and market strategy. 

As a CBD industry co-founder, Sides has long shared Medical Marijuana, Inc.’s vision of changing lives by offering high-quality CBD product. She has held several executive positions within the Company, including Chairman and COO, and has been part of the Board of Directors since 2011. In her role as Chief Legal Officer, Sides will guide the Company through her deep knowledge of legal and regulatory requirements. 

“After being deeply entrenched in Medical Marijuana, Inc.’s affairs over the years, I am excited to transition into this new role for the Company that I put my heart and soul into co-founding many years ago,” said Sides. “I could not be more proud of what our Company has accomplished, the changes we have made in this industry and the difference we have made in millions of lives. I am incredibly excited about what is ahead and have complete confidence in the talented executive team we have assembled to guide the company’s continued success.”

About Medical Marijuana, Inc.

. Medical Marijuana, Inc. () is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by  and ; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including and. Medical Marijuana, Inc. was named a top CBD producer by . Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product  has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. 

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at  or by visiting . To see Medical Marijuana, Inc.’s corporate video, .

Shareholders and consumers are also encouraged to .

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

Investor Relations Contact:

P. (858) 283-4016